Superior execution and growth

First Analysis acted as the exclusive financial advisor to Phigenics, a healthcare-focused end-to-end water risk management platform, in its majority growth investment from Battery Ventures. The partnership is intended to position Phigenics for continued growth through increased investment in new and existing products, as well as expansion into new markets.

Phigenics, headquartered in Warrenville, Ill., with accredited laboratories in Warrenville and Fayetteville, Ark., is an independent provider of water-management programs, water-quality monitoring and validation testing. Since 2004, healthcare systems and other facility operators have turned to Phigenics to improve the safety, defensibility and value of their water management programs. By combining scientific expertise, accredited testing and continuous monitoring, Phigenics helps clients mitigate waterborne pathogen risk, satisfy evolving regulatory requirements, and maintain confidence in the water systems across their entire facility footprint.

www.phigenics.com

Battery partners with exceptional founders and management teams developing category-defining businesses in markets including software and services, enterprise infrastructure/AI, and industrial technology and life-science tools. Founded in 1983, the firm backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from offices in Boston, San Francisco, Menlo Park, New York, London and Tel Aviv.

www.battery.com

First Analysis acted as the exclusive financial advisor to Mednet, a leading provider of eClinical data management software, in its sale to CRScube. The transaction brings together two established eClinical technology providers whose complementary capabilities support the growing demand for flexible, integrated clinical research solutions across North America and Asia.

Mednet is a healthcare technology company with over 24 years of experience delivering eClinical solutions for the global life sciences community. Its EDC-centric platform improves the efficiency of studies of all types and sizes, while integrated tools support the design, build and management of clinical research. Mednet’s platform has been used by over 84,000 clinical site users, having supported more than 560,000 clinical trial participants.

www.mednetsolutions.com

CRScube is a global leader in eClinical solutions, dedicated to making clinical trials more accessible, efficient and impactful. As Korea’s number one eClinical vendor, its cutting-edge technology streamlines clinical data capture and analysis while ensuring compliance with regulatory requirements worldwide. CRScube’s cost-effective platform is trusted by over 1,000 clients and used in more than 6,000 trials.

www.crscube.io

First Analysis acted as the exclusive financial advisor to Intelligent Locations, a leading provider of AI-powered real-time location software for healthcare enterprises, in its growth investment from Marlin Equity Partners, a global investment firm specializing in the software, technology and services sectors.

Intelligent Locations pioneered the development of INTRAX™, delivering an advanced AI-powered localization platform for healthcare enterprises. Its software provides healthcare professionals with intuitive tools to track, measure and analyze assets, staff safety, patient satisfaction, operational workflows, environmental conditions and more. Headquartered in Raleigh’s Research Triangle, with a Center of Excellence in Paris, the company continuously advances its predictive analytics and machine learning capabilities.

intelligentlocations.io

Marlin Equity Partners is a global investment firm with nearly $10 billion in capital commitments specializing in the software, technology and services sectors. Marlin’s mission is to partner with exceptional management teams to drive scale and enhance long-term value in businesses through its deep domain expertise, extensive network and operational transformations focused on product innovation, go-to-market enhancements, and strategic M&A. Founded in 2005, Marlin has completed over 260 acquisitions. The firm is headquartered in Los Angeles, California, with an additional office in London.

marlinequity.com

First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations.

Upfront is a mission-driven healthcare company delivering tangible outcomes to leading healthcare systems and provider groups. Its patient engagement and access platform makes each patient feel seen, guiding their care experience through personalized outreach. The backbone of the Upfront experience is its data engine, which analyzes clinical, sociodemographic, and patient-reported data. These insights, along with its advanced psychographic segmentation model, allow Upfront to individually activate patients to get the care they need while building a meaningful relationship between the patient and their health system. Upfront is rooted in partnership, leveraging best-in-class healthcare expertise to maximize the impact of technology and deliver a next-generation patient experience.

upfronthealthcare.com

Health Catalyst (HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst’s offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.

www.healthcatalyst.com